Early Life and Family
Jordi Rubiralta, born in 1973, is a key figure in the Rubiralta family, known for their significant presence in the diagnostics industry. The Rubiralta family's journey began in the 1960s, with the founding of Celsa by Jordi's father, Josep María Rubiralta, and his uncle Francisco. This marked the beginning of their entrepreneurial endeavors in Spain.
Rise to Success
Jordi Rubiralta's career is closely tied to Werfen, a diagnostics company based in Madrid. He was the chairman of Werfen until 2019 and played a crucial role in the company's expansion. Under his leadership, Werfen made strategic acquisitions, including Tem in Germany and Accriva Diagnostics in the U.S., which broadened Werfen's market reach and capabilities. He is also the president of the family office Yukon Capital, further expanding his business interests.
Key Business Strategies
Werfen's success is built on a strategy of specialization, innovation, and controlled expansion. The company focused on high-complexity areas within diagnostics, setting it apart from competitors in the basic or low-cost diagnostics market. Werfen's commitment to innovation is demonstrated by its investment in research and development. The group's strategic moves have positioned Werfen as a global leader in medical diagnostics.
Philanthropy
While specific details about Jordi Rubiralta's philanthropic activities are not widely publicized, his family's long-standing commitment to the diagnostics industry indicates a broader dedication to advancing healthcare and improving patient outcomes.